Court Upholds $115 Million Judgment in Patent Case Filed By Syntrix Biosystems Against Illumina, Inc.
November 9, 2013
On November 4, 2013, the federal judge overseeing this litigation in Tacoma, Washington denied the defendants’ motion for new trial and motion for judgment as a matter of law, finalizing the $115 million judgment against Illumina along with the eight percent running royalty ordered following a two week jury trial. The jury in this matter found for Syntrix, awarding it $96 million to which the federal court added prejudgment interest running back to 2005, and an eight percent running royalty.
Syntrix was represented by NPR partners Bradley Beckworth and Derek Gilliland, and associates Kirk Voss and Winn Cutler.